Accordingly, the fraction of activated, CD69+ and IFNα-expressing pDCs in the COVID-19 BM was significantly increased compared with in the BM of healthy controls, both in humans and mice (Fig. 5g and Extended Data Fig. 9c,e). This evidence concerns the gene IFNA1 and COVID-19.